Peptide therapy enhances targeted medicine, utilizing specific peptides for effective treatment of cancer, metabolic disorders, and neurodegenerative diseases.

The GLP-1 liraglutide showed potential benefit in reducing stroke recurrence and improving functional outcomes after minor ...

A recent study found that over a third of websites selling compounded diabetes and weight loss medications, such as Ozempic ...

Liraglutide, a GLP-1 significantly lowers the rate of recurrent stroke in patients with diabetes, with no apparent increase ...

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

Some weight loss injections include liraglutide, semaglutide, and tirzepatide. Weight loss injections involve a person injecting medications under their skin over a long period to aid weight loss.

Researchers conducted a systematic review and meta-analysis of nine randomized controlled trials assessing exenatide (Byetta, AstraZeneca), liraglutide (Victoza/Saxenda, Novo Nordisk), semaglutide ...

Katharine Lang reports Glucagon-like peptide-1 (GLP-1) receptor agonist drugs such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) are being hailed as game changers in treating adult ...

All 79 websites sold compounded semaglutide and 72.2 and 3.8 percent sold compounded tirzepatide and liraglutide, respectively. Overall, 52 websites featured a mark of certification; 50 displayed ...